Human clinical trials show promise for a pomegranate-derived anti-aging compound
Targeting aging, which is the main driver of many diseases could be an effective way to treat a wide range of illnesses and improve quality of life. Researchers at EPFL reported that a fruit-derived substance showed promise in human clinical trials in slowing mitochondrial ageing in elderly patients.
Source:
https://newatlas.com/pomegranate-anti-aging-compound-clinical-trials/60153/
